Recursion Pharmaceuticals (RXRX)

• Market cap: $1.88B
• 1 day: -3.52%
• 5 days: -0.28%
• 1 month: 10.22%
• 3 months: -22.78%
• 6 months: -41.73%
• Year to date: -15.24%
• 1 year: -34.2%
• 5 years: -89.06%
• 10 years: -88.63%
• Sector: Healthcare
• Industry: Biotechnology

About: Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

Employees: 600